Key Events This Week
05 Jan: Stock opens at Rs.399.30, down 2.73%
07 Jan: Brief recovery to Rs.401.10 (+0.74%)
08 Jan: Sharp decline to Rs.389.80 (-2.82%)
09 Jan: New 52-week and all-time low at Rs.378.10 (-3.00%)

TruAlt Bioenergy Stock Falls to 52-Week Low of Rs.384
2026-01-09 12:45:08TruAlt Bioenergy’s stock price declined to a fresh 52-week low of Rs.384 on 9 Jan 2026, marking a significant downturn for the commodity chemicals company. This new low reflects ongoing pressures on the stock, which has underperformed its sector and broader market indices over the past year.
Read full news article
TruAlt Bioenergy Stock Hits All-Time Low Amidst Continued Downtrend
2026-01-09 12:23:50TruAlt Bioenergy’s stock has reached an unprecedented low, closing just 0.05% above its 52-week low of ₹384.05, marking a significant milestone in its recent market performance. The commodity chemicals company has experienced sustained declines across multiple timeframes, reflecting a challenging period for the stock within its sector.
Read full news article
TruAlt Bioenergy is Rated Strong Sell
2025-12-29 10:10:04TruAlt Bioenergy is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 December 2025, providing investors with the latest insights into its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
TruAlt Bioenergy Falls to 52-Week Low of Rs.384.05 Amidst Market Pressure
2025-12-26 13:42:30TruAlt Bioenergy's stock reached a fresh 52-week low of Rs.384.05 today, marking a significant decline amid broader market fluctuations and sector underperformance. The stock's fall comes after a brief two-day rally, reflecting ongoing challenges within the commodity chemicals sector.
Read full news article
TruAlt Bioenergy Stock Hits All-Time Low Amidst Steep Decline
2025-12-26 13:26:34TruAlt Bioenergy’s share price has reached an all-time low, reflecting a significant downturn in market performance. The stock’s recent movements reveal a challenging phase for the company within the Commodity Chemicals sector, as it trades near its 52-week low and underperforms key benchmarks.
Read full news article








